These relationships remain independent of amyloid and tau biomarker levels, indicating that sleep fragmentation contributes to neurodegenerative changes through vascular and inflammatory mechanisms rather than direct Alzheimer’s disease (AD) pathology. The gene discussed is MAPT; the disease is Alzheimer disease.